Form 8-K - Current report:
SEC Accession No. 0001628280-20-005204
Filing Date
2020-04-21
Accepted
2020-04-21 17:13:42
Documents
1
Period of Report
2020-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K a8-kcaresactloan.htm 8-K 33254
  Complete submission text file 0001628280-20-005204.txt   34446
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 20805930
SIC: 2834 Pharmaceutical Preparations